palifermin 5.16 MG Injection

RxCUI: 2643434
RxNorm name: palifermin 5.16 MG Injection
Display name: palifermin 5.16 MG Injection
Full name: palifermin 5.16 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:55

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125103	Kepivance	palifermin	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KEPIVANCE	PALIFERMIN	Swedish Orphan Biovitrum AB (publ)	426f6e64-2c20-4a61-6d65-7320426f6e64	2025-12-17	Warnings, Adverse reactions	Exact identifier rxcui: 2643434

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
426f6e64-2c20-4a61-6d65-7320426f6e64	palifermin 5.16 MG Injection [PSN] · palifermin 5.16 MG Injection [SCD] · palifermin 5.16 MG Injection [SY]	3	22	These highlights do not include all the information needed to use Kepivance safely and effectively. See full prescribing information for KEPIVANCE. KEPIVANCE ® (palifermin) for injection, for intravenous use Initial U.S. Approval: 2004	20251217